>>> Europe : Brokers Upgrades & Downgrades - 23rd of June 2023

>>> Up
* Covestro Raised to Buy at Stifel; PT 66 euros
* Evotec SE ADRs Raised to Overweight at Morgan Stanley; PT $16
* Evotec SE Raised to Overweight at Morgan Stanley; PT 29 euros
* Neste ADRs Raised to Market Perform at Cowen; PT $20

>>> Down
* Barratt Cut to Hold at HSBC; PT 440 pence
* Berkeley Cut to Reduce at HSBC; PT 3,000 pence
* Bunzl Cut to Underperform at Jefferies; PT 2,600 pence
* Crest Nicholson Cut to Hold at HSBC; PT 230 pence
* Persimmon Cut to Hold at HSBC; PT 1,190 pence
* Talanx Cut to Hold at Berenberg; PT 50 euros
* Taylor Wimpey Cut to Hold at HSBC; PT 120 pence

>>> Initiation
* Fiserv Rated New Buy at B Riley; PT $148
* Kalray SADIR Rated New Outperform at Oddo BHF; PT 38 euros
* Medartis Rated New Buy at Research Partners
* Norwegian Air Reinstated Overweight at Barclays; PT 18 kroner

>>> Call

>After Hours Summary: SWBI +3.2% higher on earnings; TRUP +14.8% as it upd>> US

After Hours Summary: SWBI +3.2% higher on earnings; TRUP +14.8% as it updates rate status; IONQ +7.6% on higher bookings guidance; WBD +0.4% on report of potential asset sale

After Hours Gainers:

Companies trading higher in after hours in reaction to earnings/guidance: SWBI +3.2% (also increases dividend)

Companies trading higher in after hours in reaction to news: TRUP +14.8% (provides update on its rate filing approval status in CA and NY), IONQ +7.6% (increases its 2023 bookings expectations by 25%), MGTX +4.5% (to present data from Phase 1 AQUAx study and provide update on phase 2 study of AAV-hAQP1), EGLE +3.5% (to repurchase Oaktree Capital's entire 28% stake for $219.3 mln), MMM +3.2% (enters into broad class resolution to support PFAS remediation), MATX +2.2% (increases dividend), SAIC +1.3% (awarded $1.3 bln contract from Dept of Treasury), RKLB +0.9% (Electron mission will deploy seven satellites to space), CDXC +0.6% (files $125 mln mixed shelf securities offering), JAZZ +0.4% (JAZZ seeks court action to declare FDA's approval of AVDL's Lumryz as unlawful), WBD +0.4% (negotiating to sell half of Warner studio's film and TV music-publishing assets for $500 mln, according to Variety), O +0.3% (CFO to retire, names new CFO), WYNN +0.2% (launches WynnBET online casino and sports betting app in West Virginia), CSV +0.1% (names new CEO)

After Hours Losers:

Companies trading lower in after hours in reaction to earnings/guidance: XAIR -8.9%, OUST -0.7%

Companies trading lower in after hours in reaction to news: SPCE -8.9% (files mixed shelf securities offering), TAST -2.9% (stock offering by selling shareholder), TYGO -2.7% (stock offering, relates to warrants), AVDL -1.6% (JAZZ seeks court action to declare FDA's approval of AVDL's Lumryz as unlawful), GNW -0.9% (discloses security breach), ERAS -0.4% (FDA grants orphan drug designation for ERAS-801)

>>> US Close Dow -0.01% S&P +0.37% Nasdaq +0.95%

Closing Stock Market Summary

The stock market had a mixed showing today. Index level performance was supported by strong mega cap stocks, which were benefitting from some flight to safety trading as concerns about global growth rose to the fore. The broader market, though, exhibited weakness due to continued consolidation efforts and the aforementioned growth concerns. 

Apple (AAPL 187.00, +3.04, +1.7%), which hit a new 52-week high today on no news, Amazon.com (AMZN 130.15, +5.32, +4.3%), which logged a sizable gain after AWS announced a $100 million investment in a new generative AI program, and Alphabet (GOOG 123.87, +2.61, +2.2%) were some of the top performers from the mega cap space. The Vanguard Mega Cap Growth ETF (MGK) rose 1.1%. 

The major indices all settled near their best levels of the session, leaving the S&P 500 and Nasdaq with gains while the Dow Jones Industrial Average closed flattish.

The Invesco S&P 500 Equal Weight ETF (RSP), however, declined 0.4%. Market breadth also reflected more negative action under the surface. Decliners lead advancers by a nearly 2-to-1 margin at the NYSE and a greater than 3-to-2 margin at the Nasdaq. 

The underlying weakness was in response to a slate of rate hikes by the Bank of England (+50 bps to 5.00%), Norges Bank (+50 bps to 3.75%), Swiss National Bank (+25 bps to 1.75%), and Central Bank of Turkey (+650 bps to 15.0%). Those moves stoked concerns about global inflation and the lag effects of rate hikes potentially impacting global growth.

In addition, Fed Governor Michelle Bowman (FOMC voter) said in a speech that "additional policy rate increases will be necessary to bring inflation down." This followed Fed Chair Powell's commentary yesterday indicating that there could be two more rate hikes by the Fed before the end of the year if the economy performs as expected.

This morning's economic data, though, was mostly weaker than expected. Existing home sales declined 20.4% year-over-year in May while the Leading Economic Index declined for the 14th consecutive month. 

Fed Chair Powell continued his monetary policy testimony before the Senate Banking Committee today. He didn't provide any new surprises in terms of monetary policy views, yet there was consternation among committee members regarding capital requirements for banks. That understanding, coupled with the growth concerns, undercut the bank stocks. The SPDR S&P Bank ETF (KBE) fell 3.2% and the SPDR S&P Regional Banking ETF (KRE) fell 2.7%.

Weak regional bank components, along with weak energy shares, drove the Russell 2000 to underperform today, declining 0.8%.

Most of the S&P 500 sectors registered a loss. Real estate (-1.4%) and energy (-1.3%) saw the largest declines, although the cyclical financial (-0.7%), industrials (-0.7%), and materials (-0.3%) sectors underperformed. Meanwhile, strong mega cap components drove the consumer discretionary (+1.5%), communication services (+1.2%), and information technology (+0.9%) sectors to the top of the leaderboard.

Treasuries settled with losses across the curve. The 2-yr note yield rose nine basis points to 4.80% and the 10-yr note yield rose eight basis points to 3.80% in response to the aforementioned rate hikes.

  • Nasdaq Composite: +30.2% YTD
  • S&P 500: +14.1% YTD
  • Russell 2000: +4.9% YTD
  • S&P Midcap 400: +4.7% YTD
  • Dow Jones Industrial Average: +2.4% YTD

Reviewing today's economic data:

  • Q1 Current Account Balance -$219.3 bln; Prior was revised to -$216.2 bln from -$206.8 bln
  • Initial jobless claims for the week ending June 17 were unchanged at 264,000 and the four-week moving average of 255,750 was the highest since November 13, 2021. Continuing jobless claims for the week ending June 10 decreased by 13,000 to 1.759 million.
    • The key takeaway from the report is that initial jobless claims have remained elevated (third straight week above 260,000), suggesting that there is some loosening in the labor market, although the level of initial claims remains well below average levels north of 375,000 seen in all recessions since 1980.
  • Existing home sales increased 0.2% month-over-month in May to a seasonally adjusted annual rate of 4.30 million ( consensus 4.28 million) from an upwardly revised 4.29 million (from 4.28 million) in April. Sales were down 20.4% from the same period a year ago.
    • The key takeaway from the report is that the inventory of existing homes for sale remains tight, which is due in part to the strength of the labor market, the ability to work remotely, and the jump in mortgage rates that is deterring existing home owners' interest in moving.
  • Leading Indicators fell 0.7% in May ( consensus -0.8%) following a prior decline of 0.6%. 
  • The weekly EIA Natural Gas Inventories showed a build of 95 bcf versus a build of 84 bcf last week.
  • The weekly EIA Crude Oil Inventories showed a draw of 3.83 million barrels after last week's build of 7.92 million barrels.

Looking ahead to Friday, economic data is limited to the preliminary IHS Markit Manufacturing PMI (prior 48.4) and Services PMI (prior 54.9) for June at 9:45 a.m. ET. 

WSJ : The Ugly Shoes Now Worth Billions of Dollars

The Ugly Shoes Now Worth Billions of Dollars
Hokas are the chunky sneakers of choice for runners. And nurses. And waiters. And teens. And grandpas. How did shoes that were huge, weird and French conquer America’s hearts, wallets and feet?

The first time he laid eyes on the shoes that would be worth billions of dollars, Stefano Caroti wasn’t sure what he was looking at. But there was one thing the Deckers Outdoor DECK -0.88%decrease; red down pointing triangle footwear executive did know about this pair of colorful and chunky sneakers that went by the name of Hoka.

“I had never seen anything like it,” he said.

They were big, weird, contrarian and French, and there wasn’t much reason to expect they would become huge in the U.S. In fact, when Hoka’s founders sold the company to Deckers Brands in 2012, their sales were around $3 million that year.

Hoka’s sales over the past fiscal year: $1.4 billion.

These peculiar shoes have become the oversized sneakers of choice for people who are hardcore runners and people who have a hard time walking—athletes, nurses, restaurant waiters, postal workers, TV writers, cool teens and their grandpas. Some wear them because they want to. Others wear them because they have to. Either way, a great many of them develop a fascination and then an obsession with their Hokas, which have conquered the hearts, wallets and feet of American consumers.

There’s an obvious explanation for the success of any sneaker company: It’s gotta be the shoes. That applies to Hokas, too. The distinctive cushioning that creates a magical feeling made these shoes unlike any on the market. But it’s not just the shoes. Shoes alone can’t take a brand from $3 million to $1.4 billion—especially not these highly unconventional shoes.

The success of Hoka was also made possible by the brand’s counterintuitive business strategy. It turns out Hoka grew fast by moving slowly.

“Could we grow faster? Yes,” said Caroti, Deckers’ chief commercial officer and Hoka’s interim president. “Is that good for the long-term health of the brand? No.”

This was a curious thing to hear from an executive at a brand with explosive growth. But it’s not just corporate hokum. Wall Street analysts told me that Hoka’s selective distribution keeps supply below demand and maintains the premium appeal of sneakers that generally cost between $125 and $175. Hoka’s executives are pacing themselves, cautious about getting too big too soon, betting that trying to win every consumer is how a company loses its identity. They are running the business as if they are running a marathon.

That discipline is paying off. Hoka sales amounted to less than 10% of Deckers’ revenues only five years ago. Now they account for nearly 40% and Deckers has never been worth so much. This company is one of the few whose stock price has doubled over the past year for reasons that have absolutely nothing to do with AI.

The current growth rate is unsustainable, like sprinting for 26.2 miles, but its history of patient management is why investors are bullish on Hoka’s future.

“It’s something that has been one of the keys to our success,” said Colin Ingram, Hoka’s vice president of global product. “Knowing when to say yes, when to say no and when to say not yet.”

Hoka executives can afford to be judicious because there will always be a market for any product that solves problems and provides value. They say there are three key elements of Hokas—the midsole (for soft landings), the foot frame (for support) and the curved sole called a meta-rocker (for propulsion)—and the combination of stability, efficiency and cushioning helps prevent injuries and alleviate pain. Also, they’re super comfy.

The brand was founded in 2009 by Jean-Luc Diard and Nicolas Mermoud, who met at a ski race in the French Alps decades earlier. When they decided to start a company together, they gravitated toward shoes, because the footwear market was massive but the technology of shoe construction was fairly basic. Their original concept was to chase that sensation of riding a wave on a surfboard or floating down a mountain on skis—except for trail running. They called the brand Hoka One One, the Maori phrase that roughly translates to “flying over the earth.”

As they tinkered with sneakers designed to run faster downhill, they realized that shoes had something in common with modern tennis rackets, bicycle tires and their beloved skis: Bigger was better. Like so many radical innovations, the idea might sound like common sense today, but it seemed heretical when runners were smitten with minimalist shoes. Hokas were proudly maximalist. They were also pretty ugly. (They have been described by news articles and the brand’s executives as “marshmallow shoes” and “clown shoes,” bloated, engorged, wacky, bulbous, extreme, “kind of hideous,” “why?” and “just…no.”)

Hoka was introduced to the U.S. when Mermoud attended a 2009 trade show with a bag of prototypes and without a booth. He didn’t need one. Those early shoes had so little in common with the competition that almost everyone who raves about them recalls when they first encountered them.

“I remember bashing my feet into the pavement and couldn’t feel anything,” Ingram said. “I was like, OK, there’s something to this. It’s not just a crazy-looking shoe. There’s actually a benefit to it.”

The brand shipped 1,100 pairs to the U.S. and Canada in 2010, said Steven Doolan, the vice president and general manager of Hoka North America. But soon the polarizing shoes were best-sellers in specialty running stores, where owners stashed boxes in back hallways to keep them in stock. Deckers took a stake in 2012 and then had a smarter idea than investing in Hoka: buying Hoka.

The deal for an undisclosed sum was a rounding error for Deckers, which already owned Ugg boots and Teva sandals, as the company said in a regulatory filing that the acquisition was not material to its finances.

It took five years for Hoka’s sales to accelerate from less than $3 million to more than $100 million. It took six more to zoom past $1 billion.

The improbable billion-dollar brand started as a word-of-mouth phenomenon in the niche but influential running community. In recent years, Nike and Adidas have ceded ground in the running market, opening a lane for much, much smaller upstarts like Hoka and On. The business also benefited from pandemic tailwinds like hybrid work and casual office dress, as people discovered that sneakers engineered to run down trails also worked as everyday shoes on flat roads and city streets. As they got more popular, Hokas even got less ugly.

But sudden ubiquity only makes it more important to preserve scarcity. Prudence doesn’t come naturally to companies with financial incentives to grow in the short term, and the retail industry is littered with cautionary tales of brands that overestimated their appeal, flooded stores and lost their air of exclusivity and ability to command a premium pricetag. Hoka’s executives have avoided the risk of overabundance by keeping their sneakers out of the biggest big-box chains, and that careful distribution and healthy reliance on direct-to-consumer sales allowed them to control pricing even when the brand was blowing up.

“It’s easy when you’re hot like this to let anybody buy what they want to buy, but that’s the fastest way to ruin a brand,” said Matt Powell, a longtime analyst of the sneaker industry. “The short-term gains are the easiest ones to get. It’s the long-term gains that make you a successful brand.”

To grow fast, think slow. That’s the business lesson in every box of Hokas. The way to stay hot is to stoke the fire, not to douse it with gasoline. But gradual progress can be hard to accept when companies are under pressure to deliver every quarter—and because it defies the way that many of the world’s most recognizable brands were once built.

“The way you got your brand out there was that you had to be everywhere,” Doolan said. “Today you don’t have to be. You want to be in the right places in front of the right individuals.”

You also have to get the timing right. On its path to $1.4 billion in sales, the brand moseyed from running shops to outdoor specialists like REI to large retailers, though executives actually turned down the opportunity to move Hokas into Foot Locker before the pandemic. “We were not ready,” Doolan said. People had to be familiar with Hokas before they were willing to buy Hokas. Otherwise the shoes would have been hiding in plain sight on the wall. By last summer, the brand’s awareness was high enough that it was ready for one of the country’s biggest sneaker chains. “We’ve held out a little bit longer than we needed to,” Doolan said. “But now we’re more likely to have success.”

They followed a similarly conservative playbook at Dick’s Sporting Goods. “We started very slowly with them,” Caroti said. “In fact, initially, it didn’t work.” Hoka tested the market in a small number of Dick’s stores as early as 2014. They were uncharacteristically quick to end the experiment when they didn’t like what they found. “It was a bit too early,” Caroti said. “There was no consumer demand.”

It was so early that the brand wouldn’t get back into Dick’s until 2020. They started in about 10 stores and paid close attention to the sell-through rate of its limited inventory over several months. In 2021, they expanded to 40 stores. In 2022, they planned for 100 doors. But they were still in less than 20% of the chain’s locations—and it’s oddly fitting that Deckers executives sound proud of how few places you can find a pair of Hokas.

They don’t want to get out over their skis.

FT : German chemical group Covestro rejects €13bn Abu Dhabi approach

German chemical group Covestro rejects €13bn Abu Dhabi approach
State-owned oil company Adnoc seeks to diversify revenue stream and expand beyond fossil fuels

German chemical company Covestro has rebuffed a €13bn approach from the Abu Dhabi National Oil Company, putting pressure on the state-owned energy company to raise its bid if it wishes to pursue a transaction.

Adnoc’s bid of roughly €13bn, which would have been one of the largest deals this year, was rejected by Covestro on Thursday, according to people familiar with the matter. Covestro did not rule out further engagement, the people said.

The offer valued Covestro’s shares at about €55 each, about a 40 per cent premium to its undisturbed share price of about €39 per share.
That is equivalent to an almost €11bn valuation for the company’s equity, before taking debt and other factors into account.

The oil company would be supportive of management strategy, one person close to the transaction said.

Covestro and representatives for Adnoc both declined to comment.
It comes as the oil-rich emirate flexes its financial muscle, deploying years of excess hydrocarbon revenues into sectors that could help the state wean itself off oil dependency.

Covestro, one of Germany’s largest companies, is an insulation foam specialist that could help Adnoc expand its chemicals business as part of a broader diversification strategy. Adnoc, under the leadership of Sultan al-Jaber, who is also in charge of UAE’s hosting of the COP28 climate summit, has sought to maximise the value of the Gulf state’s resources by expanding in downstream production.

The oil company has also been trying to make its large energy-intensive plants less dependent on fossil fuels, investing in green technologies and recycling solutions that are increasingly attractive as demand grows for less environmentally hazardous components.

The rise in energy prices that has buoyed fossil fuel companies has presented the opposite challenge to chemical companies such as Covestro. In March, the company warned that profits this year would be “well below” those in 2022.

Last year, its earnings before interest, tax, depreciation and amortisation were €1.6bn, almost half the figure from the year before.
“The sharp rise in energy and raw material prices during the year, especially in Europe, put a strain on the company,” Covestro said at the time.

The European gas crisis, which hit Germany particularly hard, prompted concern about the future of energy-intensive industries such as chemicals on the continent. BASF, the world’s largest chemical company by revenue, last year announced it would “permanently” downsize operations in Germany.

Shares in Covestro, which was spun out of Bayer in 2015, have roughly halved since a peak five years ago. They stood at €47.90 on Thursday afternoon, up by almost 20 per cent since the start of the week following reports from Bloomberg about Adnoc’s approach.
The shares had gained about 1.6 per cent by Thursday afternoon.

Adnoc has earmarked $150bn to invest in natural gas, chemicals and clean energy, as companies transition away from relying on fossil fuels. The state-owned company is committed to expanding domestic production of crude oil, natural gas and related products, such as plastics.

It already owns a majority stake in Borouge, a joint venture with Austria’s Borealis.

>>> US Research Calls

Research Calls

  • Upgrades:
    • Agree Realty (ADC) upgraded to Buy from Neutral at Mizuho; tgt $70
    • Anheuser-Busch InBev (BUD) upgraded to Buy from Hold at Deutsche Bank
    • DiaMedica Therapeutics (DMAC) upgraded to Outperform from Perform at Oppenheimer; tgt $7
    • Grab (GRAB) upgraded to Neutral from Underweight at JP Morgan; tgt raised to $3.10
    • Kellogg (K) upgraded to Mkt Perform from Underperform at Bernstein; tgt $62
    • SAP SE (SAP) upgraded to Hold from Underperform at Jefferies
    • Shell plc (SHEL) upgraded to Equal-Weight from Underweight at Morgan Stanley
    • XP (XP) upgraded to Buy from Neutral at BofA Securities
  • Downgrades:
    • AES (AES) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $23
    • Alcoa (AA) downgraded to Underweight from Equal-Weight at Morgan Stanley; tgt lowered to $33
    • Celanese (CE) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $116
    • Chemours (CC) downgraded to Neutral from Buy at BofA Securities; tgt lowered to $37
    • DigitalOcean (DOCN) downgraded to Underweight from Neutral at Piper Sandler; tgt $35
    • Dow (DOW) downgraded to Underperform from Neutral at BofA Securities; tgt lowered to $55
    • Eneti (NETI) downgraded to Neutral from Buy at Citigroup; tgt $14
    • Equinix (EQIX) downgraded to Perform from Outperform at Oppenheimer
    • Equinor (EQNR) downgraded to Underweight from Equal-Weight at Morgan Stanley
    • Mercury (MRCY) downgraded to Neutral from Outperform at Robert W. Baird; tgt lowered to $40
    • PagSeguro Digital (PAGS) downgraded to Neutral from Buy at New Street; tgt lowered to $14
    • Tesla (TSLA) downgraded to Equal-Weight from Overweight at Morgan Stanley; tgt raised to $250
  • Others:
    • Andersons (ANDE) initiated with a Buy at ROTH MKM; tgt $55
    • Archer-Daniels (ADM) initiated with a Buy at ROTH MKM; tgt $92
    • Boston Scientific (BSX) placed on 90-day Positive Catalyst Watch; tgt raised to $63
    • Burford Capital (BUR) resumed with a Buy at Berenberg
    • Bunge (BG) initiated with a Buy at ROTH MKM; tgt $138
    • Caterpillar (CAT) initiated with a Neutral at DA Davidson; tgt $263
    • Despegar.com (DESP) initiated with a Buy at B. Riley Securities; tgt $10
    • Expedia Group (EXPE) initiated with a Buy at B. Riley Securities; tgt $160
    • Humacyte (HUMA) initiated with an Overweight at Cantor Fitzgerald; tgt $6
    • Outbrain Inc. (OB) initiated with a Neutral at B. Riley Securities; tgt $5
    • Pembina Pipeline (PBA) initiated with a Buy at Stifel
    • Sea Limited (SE) resumed with a Buy at DZ Bank; tgt $75
    • Taboola (TBLA) initiated with a Buy at B. Riley Securities; tgt $5
    • Terns Pharmaceuticals (TERN) initiated with a Buy at Mizuho; tgt $16
    • Toro (TTC) initiated with a Buy at DA Davidson; tgt $117
    • TripAdvisor (TRIP) initiated with a Buy at B. Riley Securities; tgt $25
    • trivago (TRVG) initiated with a Neutral at B. Riley Securities; tgt $2
    • TScan Therapeutics (TCRX) initiated with an Outperform at Wedbush; tgt $8
    • Zura Bio Limited (ZURA) initiated with a Buy at Guggenheim; tgt $20